Security
Gilead Sciences, Inc. Common Stock · GILD
GILDNASDAQCommon stockCurrentCIK 882095Updated Oct 31, 2026
GILD price & chart
Loading TradingView…
NASDAQ:GILD on TradingView ↗About the company
Gilead and Kite Oncology are working to transform how cancer is treated. We are innovating with next-generation therapies, combinations and technologies to deliver improved outcomes for people with cancer. We are purposefully building our oncology portfolio and pipeline to address the greatest gaps in care. From antibody-drug conjugate technologies and small molecules to cell therapy-based approaches, we are creating new possibilities for people with cancer.
In the news
Seeking Alpha
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth ↗
Bispecific biotech Bambusa and Parkinson’s-focused Aspen slide on trading debuts ↗
Gilead: Q3 Earnings Overview - It's Time To Consider Selling After Stellar Year ↗
SEC disclosures
GILEAD SCIENCES, INC. files 8-K: Material Event ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
144 filing
4 filing
144 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 58,533,000,000Source | 54,525,000,000Source | 49,362,000,000Source | 55,721,000,000Source | 53,579,000,000Source | 56,278,000,000Source | 56,434,000,000Source | 56,292,000,000Source | 59,023,000,000Source | 58,995,000,000Source | 62,125,000,000Source | 63,171,000,000Source |
| Property, Plant and Equipment, NetUSD | 5,500,000,000Source | 5,391,000,000Source | 5,833,000,000Source | 5,459,000,000Source | 5,346,000,000Source | 5,638,000,000Source | 5,421,000,000Source | 5,321,000,000Source | 5,606,000,000Source | 5,414,000,000Source | 5,317,000,000Source | 5,475,000,000Source |
| GoodwillUSD | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 17,970,000,000Source | 20,546,000,000Source | 14,032,000,000Source | 18,566,000,000Source | 22,832,000,000Source | 16,382,000,000Source | 19,355,000,000Source | 23,428,000,000Source | 16,978,000,000Source | 19,948,000,000Source | 26,454,000,000Source | 28,894,000,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | — | — | — | — | — | — | — | — | — | 5,412,000,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 5,095,000,000Source | 4,587,000,000Source | 5,055,000,000Source | 4,781,000,000Source | 4,663,000,000Source | 4,741,000,000Source | 4,388,000,000Source | 4,669,000,000Source | 4,913,000,000Source | 4,420,000,000Source | 4,660,000,000Source | 4,777,000,000Source |
| Inventory, NetUSD | 1,785,000,000Source | 1,869,000,000Source | 1,953,000,000Source | 1,825,000,000Source | 2,026,000,000Source | 1,914,000,000Source | 1,759,000,000Source | 1,853,000,000Source | 1,774,000,000Source | 1,710,000,000Source | 1,787,000,000Source | 1,507,000,000Source |
| Assets, CurrentUSD | 17,874,000,000Source | 14,779,000,000Source | 13,945,000,000Source | 14,718,000,000Source | 12,317,000,000Source | 18,641,000,000Source | 16,901,000,000Source | 14,041,000,000Source | 18,342,000,000Source | 19,173,000,000Source | 16,085,000,000Source | 14,443,000,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,645,000,000Source | 3,287,000,000Source | 3,759,000,000Source | 2,899,000,000Source | 2,856,000,000Source | 4,342,000,000Source | 2,828,000,000Source | 2,800,000,000Source | 4,024,000,000Source | 3,052,000,000Source | 2,374,000,000Source | 1,774,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | — | — | — | — | — | — | 532,000,000Source | 515,000,000Source | 581,000,000Source | 505,000,000Source |
| Other Assets, NoncurrentUSD | 4,873,000,000Source | 5,494,000,000Source | 4,751,000,000Source | 4,031,000,000Source | 4,770,000,000Source | 4,554,000,000Source | 3,871,000,000Source | 5,188,000,000Source | 4,845,000,000Source | 6,146,000,000Source | 4,792,000,000Source | 4,800,000,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 1,000,000Source | 1,000,000Source | 1,000,000Source | 1,000,000Source | 1,000,000Source | 1,000,000Source | 1,000,000Source | 1,000,000Source | 1,000,000Source | 1,000,000Source | 1,000,000Source | 1,000,000Source |
| Additional Paid in CapitalUSD | 8,678,000,000Source | 7,327,000,000Source | 9,532,000,000Source | 8,367,000,000Source | 7,022,000,000Source | 9,305,000,000Source | 8,138,000,000Source | 6,813,000,000Source | 8,932,000,000Source | 7,700,000,000Source | 6,500,000,000Source | 5,550,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | 12,825,000,000Source | 11,073,000,000Source | 2,200,000,000Source | 11,325,000,000Source | 11,165,000,000Source | 14,131,000,000Source | 10,931,000,000Source | 10,656,000,000Source | 13,730,000,000Source | 11,497,000,000Source | 16,304,000,000Source | 15,687,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 36,000,000Source | 73,000,000Source | 95,000,000Source | -18,000,000Source | 93,000,000Source | 78,000,000Source | 92,000,000Source | 69,000,000Source | 39,000,000Source | 132,000,000Source | 28,000,000Source | 2,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | 21,540,000,000Source | 18,475,000,000Source | 11,829,000,000Source | 19,674,000,000Source | 18,281,000,000Source | 23,515,000,000Source | 19,162,000,000Source | 17,539,000,000Source | 22,703,000,000Source | 19,330,000,000Source | 22,833,000,000Source | 21,240,000,000Source |
| Liabilities and EquityUSD | 58,533,000,000Source | 54,525,000,000Source | 49,362,000,000Source | 55,721,000,000Source | 53,579,000,000Source | 56,278,000,000Source | 56,434,000,000Source | 56,292,000,000Source | 59,023,000,000Source | 58,995,000,000Source | 62,125,000,000Source | 63,171,000,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 12,298,000,000Source | 11,725,000,000Source | 11,020,000,000Source | 11,189,000,000Source | 10,781,000,000Source | 9,476,000,000Source | 12,344,000,000Source | 13,015,000,000Source | 11,813,000,000Source | 12,004,000,000Source | 11,280,000,000Source | 11,237,000,000Source |
| Operating Lease, Liability, CurrentUSD | — | — | — | — | — | — | — | — | 102,000,000Source | 113,000,000Source | 125,000,000Source | 111,000,000Source |
| Accounts Payable, CurrentUSD | 808,000,000Source | 903,000,000Source | 674,000,000Source | 582,000,000Source | 537,000,000Source | 645,000,000Source | 737,000,000Source | 622,000,000Source | 715,000,000Source | 833,000,000Source | 550,000,000Source | 905,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | — | — | — | — | — | — | 503,000,000Source | 498,000,000Source | 546,000,000Source | 467,000,000Source |
| Deferred Income Tax Liabilities, NetUSD | 597,000,000Source | 794,000,000Source | 333,000,000Source | 652,000,000Source | 907,000,000Source | 392,000,000Source | 709,000,000Source | 933,000,000Source | 402,000,000Source | 724,000,000Source | 1,588,000,000Source | 2,673,000,000Source |
| Other Liabilities, NoncurrentUSD | 1,182,000,000Source | 1,396,000,000Source | 1,490,000,000Source | 1,290,000,000Source | 1,418,000,000Source | 1,200,000,000Source | 1,337,000,000Source | 1,395,000,000Source | 1,165,000,000Source | 1,295,000,000Source | 1,280,000,000Source | 1,179,000,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -84,000,000Source | -84,000,000Source | -84,000,000Source | -84,000,000Source | -84,000,000Source | -84,000,000Source | -84,000,000Source | -84,000,000Source | -84,000,000Source | -84,000,000Source | -84,000,000Source | -31,000,000Source |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | 392,000,000Source | 1,432,000,000Source |
| Long-term Debt, Excluding Current Maturities | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Long-term Debt, Current MaturitiesUSD | 2,806,000,000Source | 1,812,000,000Source | 2,414,000,000Source | 2,806,000,000Source | 1,809,000,000Source | 1,313,000,000Source | 2,806,000,000Source | 3,667,000,000Source | 2,807,000,000Source | 1,815,000,000Source | 1,798,000,000Source | 2,273,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 22,135,000,000Source | 21,437,000,000Source | 23,832,000,000Source | 22,140,000,000Source | 21,540,000,000Source | 20,861,000,000Source | 22,146,000,000Source | 21,527,000,000Source | 22,129,000,000Source | 24,896,000,000Source | 23,189,000,000Source | 22,957,000,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 3,052,000,000Source | 1,253,000,000Source | — | 1,960,000,000Source | — | 1,315,000,000Source | 8,510,000,000Source | 480,000,000Source | 5,613,000,000Source | 4,566,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 218,000,000Source | 209,000,000Source | 894,000,000Source | 835,000,000Source | 766,000,000Source | 637,000,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -134,000,000Source | -79,000,000Source | 367,000,000Source | -139,000,000Source | -157,000,000Source | 406,000,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 52,000,000Source | 223,000,000Source | 1,036,000,000Source | 426,000,000Source | 842,000,000Source | 310,000,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -67,000,000Source | -105,000,000Source | -132,000,000Source | 290,000,000Source | -347,000,000Source | 226,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | 179,000,000Source | -199,000,000Source | 160,000,000Source | -1,844,000,000Source | -962,000,000Source | -1,552,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 2,544,000,000Source | 1,757,000,000Source | 10,019,000,000Source | 10,828,000,000Source | 8,006,000,000Source | 9,072,000,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | 109,000,000Source | 273,000,000Source | 1,070,000,000Source | 4,840,000,000Source | 1,152,000,000Source | 1,797,000,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 1,770,000,000Source | -415,000,000Source | -4,793,000,000Source | -3,449,000,000Source | -2,265,000,000Source | -2,466,000,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | 17,000,000Source | 23,000,000Source | -2,000,000Source | -58,000,000Source | 1,000,000Source | 1,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 117,000,000Source | 104,000,000Source | 563,000,000Source | 523,000,000Source | 585,000,000Source | 728,000,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 419,000,000Source | 730,000,000Source | 1,922,000,000Source | 1,150,000,000Source | 1,000,000,000Source | 1,396,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -4,239,000,000Source | -3,426,000,000Source | -7,745,000,000Source | -3,433,000,000Source | -5,125,000,000Source | -6,469,000,000Source |
| Dividends paid | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | -179,000,000Source | -176,000,000Source | -440,000,000Source | -281,000,000Source | -279,000,000Source | -173,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 65,000,000Source | -2,065,000,000Source | -2,428,000,000Source | 3,906,000,000Source | 673,000,000Source | 74,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 7,330,000,000Source | 5,037,000,000Source | 3,179,000,000Source | 5,144,000,000Source | 7,628,000,000Source | 7,926,000,000Source | 7,564,000,000Source | 9,991,000,000Source | 6,085,000,000Source | 5,412,000,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 1,036,000,000Source | 951,000,000Source | 891,000,000Source | 907,000,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 3,215,000,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -11,000,000Source | 19,000,000Source | 92,000,000Source | -40,000,000Source | 57,000,000Source | -63,000,000Source |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | — | — | — | — | 596,000,000Source | 599,000,000Source | 2,390,000,000Source | 2,386,000,000Source | 2,339,000,000Source | 1,780,000,000Source |
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | 894,000,000Source | 969,000,000Source | 796,000,000Source | 645,000,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 2,400,000,000Source | 2,400,000,000Source | 2,300,000,000Source | 1,800,000,000Source |
| DepreciationUSD | — | — | 90,000,000Source | 94,000,000Source | 98,000,000Source | 93,000,000Source | 93,000,000Source | 97,000,000Source | 370,000,000Source | 381,000,000Source | 354,000,000Source | 323,000,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | — | — | 483,000,000Source | 258,000,000Source | 343,000,000Source | 142,000,000Source | 142,000,000Source | -426,000,000Source | 451,000,000Source | -274,000,000Source | — | — |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | — | — | 494,000,000Source | 257,000,000Source | 340,000,000Source | 143,000,000Source | 131,000,000Source | -436,000,000Source | 404,000,000Source | — | — | — |
| GoodwillUSD | — | — | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source | 8,314,000,000Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | 0Source | 1,750,000,000Source | 1,750,000,000Source | 190,000,000Source | — | 0Source | 590,000,000Source | 4,180,000,000Source | 50,000,000Source | 2,700,000,000Source |
| Income Tax Expense (Benefit)USD | — | — | 589,000,000Source | -297,000,000Source | 242,000,000Source | 468,000,000Source | 559,000,000Source | 334,000,000Source | 1,286,000,000Source | 211,000,000Source | 1,247,000,000Source | 1,248,000,000Source |
| InterestExpenseNonoperatingUSD | — | — | 256,000,000Source | 238,000,000Source | 247,000,000Source | 254,000,000Source | 240,000,000Source | 260,000,000Source | 1,024,000,000Source | 977,000,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 3,052,000,000Source | 1,253,000,000Source | -10,496,000,000Source | 1,960,000,000Source | 2,021,000,000Source | 1,315,000,000Source | 8,510,000,000Source | 480,000,000Source | 5,665,000,000Source | 4,592,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | 0Source | -52,000,000Source | -26,000,000Source |
| Nonoperating Income (Expense)USD | — | — | 569,000,000Source | 306,000,000Source | 387,000,000Source | 208,000,000Source | 235,000,000Source | -328,000,000Source | 798,000,000Source | 6,000,000Source | 198,000,000Source | -581,000,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 169,000,000Source | 163,000,000Source | 165,000,000Source | 162,000,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -1,000,000Source | -4,000,000Source | -1,000,000Source | -6,000,000Source | -2,000,000Source | 4,000,000Source | -1,000,000Source | -2,000,000Source | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 166,000,000Source | 252,000,000Source | 408,000,000Source | 422,000,000Source | 232,000,000Source | 309,000,000Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | — | — | — | 36,000,000Source | 0Source | 55,000,000Source | 327,000,000Source | 1,334,000,000Source | 1,590,000,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 7,769,000,000Source | 7,545,000,000Source | 7,803,000,000Source | 7,082,000,000Source | 6,960,000,000Source | 6,667,000,000Source | 29,443,000,000Source | 28,754,000,000Source | 27,116,000,000Source | 27,281,000,000Source |
| Cost of RevenueUSD | — | — | 1,569,000,000Source | 1,574,000,000Source | 1,579,000,000Source | 1,501,000,000Source | 1,445,000,000Source | 1,540,000,000Source | 6,234,000,000Source | 6,251,000,000Source | 6,498,000,000Source | 5,657,000,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | 1,357,000,000Source | 1,433,000,000Source | 1,921,000,000Source | 1,365,000,000Source | 1,451,000,000Source | 1,258,000,000Source | 5,774,000,000Source | 6,091,000,000Source | 6,090,000,000Source | 5,673,000,000Source |
| Operating Income (Loss)USD | — | — | 3,327,000,000Source | 888,000,000Source | -10,394,000,000Source | 2,474,000,000Source | 2,586,000,000Source | 2,237,000,000Source | 10,022,000,000Source | 1,662,000,000Source | 7,605,000,000Source | 7,330,000,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -1,000,000Source | -4,000,000Source | -1,000,000Source | -6,000,000Source | -2,000,000Source | 4,000,000Source | -1,000,000Source | -2,000,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 3,641,000,000Source | 956,000,000Source | -10,254,000,000Source | 2,429,000,000Source | 2,580,000,000Source | 1,649,000,000Source | 9,796,000,000Source | 690,000,000Source | 6,859,000,000Source | 5,814,000,000Source |
| Income Tax Expense (Benefit)USD | — | — | 589,000,000Source | -297,000,000Source | 242,000,000Source | 468,000,000Source | 559,000,000Source | 334,000,000Source | 1,286,000,000Source | 211,000,000Source | 1,247,000,000Source | 1,248,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | 0Source | -52,000,000Source | -26,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 3,052,000,000Source | 1,253,000,000Source | -10,496,000,000Source | 1,960,000,000Source | 2,021,000,000Source | 1,315,000,000Source | 8,510,000,000Source | 480,000,000Source | 5,665,000,000Source | 4,592,000,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 2.46Source | 1Source | -8.45Source | 1.57Source | 1.63Source | 1.06Source | 6.84Source | 0.38Source | 4.54Source | 3.66Source |
| Earnings Per Share, DilutedUSD per share | — | — | 2.43Source | 1Source | -8.45Source | 1.56Source | 1.61Source | 1.04Source | 6.78Source | 0.38Source | 4.5Source | 3.64Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 1,243,000,000Source | 1,247,000,000Source | 1,243,000,000Source | 1,245,000,000Source | 1,242,000,000Source | 1,246,000,000Source | 1,244,000,000Source | 1,247,000,000Source | 1,248,000,000Source | 1,255,000,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 1,254,000,000Source | 1,254,000,000Source | 1,243,000,000Source | 1,255,000,000Source | 1,254,000,000Source | 1,259,000,000Source | 1,255,000,000Source | 1,255,000,000Source | 1,258,000,000Source | 1,262,000,000Source |
| Interest Expense (non-operating)USD | — | — | 256,000,000Source | 238,000,000Source | 247,000,000Source | 254,000,000Source | 240,000,000Source | 260,000,000Source | 1,024,000,000Source | 977,000,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 2,400,000,000Source | 2,400,000,000Source | 2,300,000,000Source | 1,800,000,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | — | — | 0.79Source | 0.77Source | 0.82Source | 0.79Source | 0.82Source | 0.79Source | 3.16Source | 3.08Source | 0.75Source | 2.92Source |
| Costs and ExpensesUSD | — | — | 4,442,000,000Source | 6,657,000,000Source | 18,197,000,000Source | 4,608,000,000Source | 4,374,000,000Source | 4,430,000,000Source | 19,421,000,000Source | 27,092,000,000Source | 19,511,000,000Source | 19,951,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 8,310,000,000Source | -876,000,000Source | 5,467,000,000Source | 4,439,000,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 944,000,000Source | 935,000,000Source |
| Nonoperating Income (Expense)USD | — | — | 569,000,000Source | 306,000,000Source | 387,000,000Source | 208,000,000Source | 235,000,000Source | -328,000,000Source | 798,000,000Source | 6,000,000Source | 198,000,000Source | -581,000,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 169,000,000Source | 163,000,000Source | 165,000,000Source | 162,000,000Source |
Offerings
Registration 333-298081
Filing attachments
tm2622548d1_ex99-1.htm · SCHEDULE 13D/A · 2026-08-07
Exhibit 99.1 Schedule I The name and present principal occupation of each of the executive officers and directors of Gilead Sciences, Inc. are set forth below. Unless otherwise noted, each of these persons have as their business address c/o Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404. Name Title Citizenship Principal Occupation and, if not …
Read attachment ↗tm2622548d1_ex99-2.htm · SCHEDULE 13D/A · 2026-08-07
Exhibit 99.2 [***] INDICATES INFORMATION THAT HAS BEEN OMITTED FROM THIS EXHIBIT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED INFORMATION PURSUANT TO RULE 24b-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED ARCUS BIOSCIENCES, INC. AMENDED & RESTATED INVESTOR RIGHTS AGREEMENT This Amended and Restated Investor Rights Agreement (this “ Agreement ”) is made as of August 5, 2026 (the “Effective Dat…
Read attachment ↗tm2615045d1_ex4-2.htm · 8-K · 2026-05-20
EX-4.2 3 tm2615045d1_ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 ELEVENTH SUPPLEMENTAL INDENTURE GILEAD SCIENCES, INC. AND COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION, AS SUCCESSOR TO WELLS FARGO BANK, NATIONAL ASSOCIATION, AS TRUSTEE Eleventh Supplemental Indenture Dated as of May 20, 2026 Supplementing the Indenture Dated as of March 30, 2011 4.250% Senior Notes due 2028 4.400% Senior Notes due 2029 4.600% Senior Notes due 2031 4.900% Senior Notes due 2034 THIS ELEVENTH SUPPLEMEN…
Read attachment ↗tm2612748d1_ex99-1.htm · 8-K · 2026-04-28
EX-99.1 2 tm2612748d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 CONTACTS: Ashleigh Koss, Media Public_affairs@gilead.com Jacquie Ross, Investors investor_relations@gilead.com GILEAD SCIENCES COMPLETES ACQUISITION OF ARCELLX AHEAD OF POTENTIAL COMMERCIAL LAUNCH OF ANITO-CEL FOSTER CITY, Calif., April 28, 2026 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Arcellx, Inc. (Nasdaq: ACLX). Under the terms of the transa…
Read attachment ↗tm267075d1_ex99-1.htm · SC TO-C · 2026-02-23
Exhibit 99.1 Good Morning - We are pleased to share that we have just announced a definitive agreement to acquire Arcellx for $115 per share in cash at closing and one contingent value right of $5 per share, which represents an implied equity value of $7.8 billion payable at closing. As a reminder, Gilead already owns ~11.5% of Arcellx outstanding common stock. Full text of the release is included at the end of this email. More than three years into our collaboration with Arcellx, we unders…
Read attachment ↗tm267075d1_ex99-2.htm · SC TO-C · 2026-02-23
Exhibit 99.2 Forward-Looking Statements This communication contains forward-looking statements related to Gilead Sciences, Inc. (“Gilead”), Arcellx, Inc. (“Arcellx”) and the acquisition of Arcellx by Gilead that are subject to risks, uncertainties and other factors. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including all statements regarding the intent, belief or current expectation of Gilead and Arcellx and members …
Read attachment ↗